Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence by Ryo Shimizu, Hideyuki Tamai, Yoshiyuki Ida, Shuya Maeshima, Naoki Shingaki, Takao Maekita, Mikitaka Iguchi, Masayuki Kitano

Get full text

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis by Hideyuki Tamai, Hiroki Minamiguchi, Yoshiyuki Ida, Naoki Shingaki, Tokuro Muroki, Shuya Maeshima, Ryo Shimizu, Junpei Okamura, Takao Koyama, Taisei Nakao, Tetsuo Sonomura

Get full text

Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus by Hideyuki Tamai, Yoshiyuki Ida, Akira Kawashima, Naoki Shingaki, Ryo Shimizu, Kosaku Moribata, Tetsushi Nasu, Takao Maekita, Mikitaka Iguchi, Jun Kato, Taisei Nakao, Masayuki Kitano

Get full text

The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients by Shinya Taki, Hideyuki Tamai, Yoshiyuki Ida, Naoki Shingaki, Akira Kawashima, Ryo Shimizu, Kosaku Moribata, Takao Maekita, Mikitaka Iguchi, Jun Kato, Taisei Nakao, Masayuki Kitano

Get full text

Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus by Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Akira Kawashima, Yoshimasa Maeda, Toru Niwa, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masao Ichinose

Get full text